The importance of CD4+ T cells in tumor rejection was demonstrated by the fact that none of the vaccinated CD4 knockout mice rejected the challenge tumor, while all vaccinated wild-type mice did, and a significant portion of the CD8 knockout mice was able to reject the challenge tumor (41). The gene discussed is CD8A; the disease is neoplasm.